Item
1.01.
|
Entry
into a Material Definitive Agreement.
|
On May 14, 2021, Tonix Pharmaceuticals
Holding Corp. (the “Company”) entered into a purchase agreement, dated as of May 14, 2021 (the “Purchase Agreement with
Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park has committed to purchase up to $80.0 million
of shares (the “Purchase Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”).
Concurrently with entering into the Purchase Agreement, the Company also entered into a registration rights agreement with Lincoln Park,
pursuant to which it agreed to take certain actions relating to the registration under the Securities Act of 1933, as amended (the “Securities
Act”), of the offer and sale of the shares of Common Stock available for issuance under the Purchase Agreement (the “Registration
Rights Agreement”).
Beginning on the Commencement
Date (as defined below) and thereafter, the Company has the right, in its sole discretion, to present Lincoln Park with a purchase notice
(a “Regular Purchase Notice”), directing Lincoln Park to purchase up to 1,000,000 Purchase Shares (the “Regular Purchase
Amount”) provided that the closing sale price of the Common Stock on the purchase date is not below a threshold price set forth
in the Purchase Agreement (a “Regular Purchase”). The Regular Purchase Amount may be increased to up to 1,500,000 shares if
the closing sale price of the Common Stock on the applicable purchase date equals or exceeds certain higher threshold prices set forth
in the Purchase Agreement. The Company and Lincoln Park may mutually agree to increase the Regular Purchase Amount with respect to any
Regular Purchase under the Purchase Agreement, provided that Lincoln Park’s maximum committed purchase obligation under any single
Regular Purchase shall not exceed 10,000,000 shares. The above-referenced share amount limitations and closing sale price thresholds are
subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction
as provided in the Purchase Agreement. The purchase price per share for each Regular Purchase will be based on prevailing market prices
of the Common Stock immediately preceding the time of sale as computed in accordance with the terms set forth in the Purchase Agreement.
There are no upper limits on the price per share that Lincoln Park must pay for shares of Common Stock under the Purchase Agreement. Lincoln
Park may not assign or transfer its rights and obligations under the Purchase Agreement.
If the Company directs
Lincoln Park to purchase the maximum number of shares of Common Stock that the Company may sell in a Regular Purchase, then in addition
to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln
Park to purchase additional shares of Common Stock in an “accelerated purchase” (each, an “Accelerated Purchase”)
and an “additional accelerated purchase” (each, an “Additional Accelerated Purchase”) (including multiple Additional
Accelerated Purchases on the same trading day) as provided in the Purchase Agreement. The purchase price per share for each Accelerated
Purchase and Additional Accelerated Purchase will be based on market prices of the Common Stock on the applicable purchase date for such
Accelerated Purchases and such Additional Accelerated Purchases.
The purchase price of Regular Purchases, Accelerated Purchases and Additional Accelerated
Purchases will be adjusted for any reorganization, recapitalization, non-cash dividend,
stock split, reverse stock split or other similar transaction occurring during the business days used to compute the purchase price.
The aggregate number of shares that the Company can sell to Lincoln Park under the Purchase Agreement may in no case exceed 65,819,361
shares (subject to adjustment as described above) of the Common Stock (which is equal to approximately 19.99% of the shares of the Common
Stock outstanding immediately prior to the execution of the Purchase Agreement) (the “Exchange Cap”), unless (i) stockholder
approval is obtained to issue Purchase Shares above the Exchange Cap, in which case the Exchange Cap will no longer apply, or (ii) the
average price of all applicable sales of our Common Stock to Lincoln Park under the Purchase Agreement equals or exceeds $0.9892 per
share (which represents the lower of (A) the official closing price of our Common Stock on Nasdaq on the trading day immediately preceding
the date of the Purchase Agreement and (B) the average official closing price of our Common Stock on Nasdaq for the five consecutive
trading days ending on the trading day immediately preceding the date of the Purchase Agreement, adjusted such that the transactions
contemplated by the Purchase Agreement are exempt from the Exchange Cap limitation under applicable Nasdaq rules).
In all cases, the
Purchase Agreement also prohibits the Company from directing Lincoln Park to purchase any shares of Common Stock if those shares,
when aggregated with all other shares of Common Stock then beneficially owned by Lincoln Park (as calculated pursuant to Section
13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 thereunder), would result in Lincoln Park beneficially
owning more than 4.99% (which Lincoln Park may increase up to 9.99% upon 61 days’ prior written notice to us) of the then
total outstanding shares of Common Stock.
The Company issued 1,280,000 shares of Common Stock to Lincoln Park as
a commitment fee in connection with entering into the Purchase Agreement (the “Commitment Shares” and together
with the Purchase Shares, the “Shares”).
The Purchase Agreement
contains customary representations, warranties, covenants, closing conditions and indemnification and termination provisions. Sales under
the Purchase Agreement may commence only after certain conditions have been satisfied (the date on which all requisite conditions have
been satisfied, the “Commencement Date”), which conditions include the delivery to Lincoln Park of a prospectus supplement
covering the shares of Common Stock issued or sold by the Company to Lincoln Park under the Purchase Agreement, the filing with The Nasdaq
Stock Market of a Listing of Additional Shares notification with respect to the Shares and Nasdaq having raised no objection to the consummation
of transactions contemplated under the Purchase Agreement, and the receipt by Lincoln Park of a customary opinion of counsel and other
certificates and closing documents. We anticipate that such conditions will be satisfied on or around May 14, 2021.
The
Purchase Agreement may be terminated by the Company at any time, at its sole discretion, without any cost or penalty, by giving one business
day notice to Lincoln Park to terminate the Purchase Agreement. Lincoln Park has covenanted not to cause or engage in any manner whatsoever,
any direct or indirect short selling or hedging of the Common Stock. Although the Company has agreed to reimburse Lincoln Park for a
limited portion of the fees it incurred in connection with the Purchase Agreement, the Company did not pay any additional amounts to
reimburse or otherwise compensate Lincoln Park in connection with the transaction, other than the issuance of the Commitment Shares.
There
are no limitations on use of proceeds, financial or business covenants, restrictions on future financings (other than restrictions on
the Company’s ability to enter into variable rate transactions described in the Purchase Agreement), rights of first refusal, participation
rights, penalties or liquidated damages in the Purchase Agreement. The Company may deliver Purchase Notices under the Purchase Agreement,
subject to market conditions, and in light of its capital needs from time to time and under the limitations contained in the Purchase
Agreement. Any proceeds that the Company receives under the Purchase Agreement are expected to be used for working capital and general
corporate purposes.
The
issuance of the Purchase Shares and Commitment Shares have been registered pursuant to the Company’s effective shelf registration
statement on Form S-3 (File No. 333-254975) (the “Registration Statement”), and the related base prospectus
included in the Registration Statement, as supplemented by a prospectus supplement to be filed on or around the Commencement Date (the
“Prospectus Supplement”). A copy of the legal opinion as to the legality of the Shares is filed as Exhibit 5.01 attached
hereto.
The
foregoing is a summary description of certain terms of the Purchase Agreement and the Registration Rights Agreement and, by its
nature, is incomplete. Copies of the Purchase Agreement and the Registration Rights Agreement are filed as Exhibits 10.01 and 10.02
attached hereto. The foregoing descriptions of the Purchase Agreement and the Registration Rights Agreement are qualified in their
entirety by reference to such exhibits. The Purchase Agreement and Registration Rights Agreement contain customary representations
and warranties, covenants and indemnification provisions that the parties made to, and solely for the benefit of, each other in the context of all of the terms
and conditions of such agreements and in the context of the specific relationship between the parties thereto. The provisions of the
Purchase Agreement and Registration Rights Agreement, including any representations and warranties contained therein, are not for the
benefit of any party other than the parties thereto and are not intended as documents for investors and the public to obtain factual
information about the current state of affairs of the parties thereto. Rather, investors and the public should look to other disclosures
contained in the Company’s annual, quarterly and current reports it may file with the Securities and Exchange Commission (the “SEC”).
The
information contained in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer
to buy the shares of the Company’s Common Stock discussed herein, nor shall there be any offer, solicitation or sale of the shares
in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such jurisdiction.